Article
The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
Breast cancer research and treatment - 1 Jul 2008
Li Wen-Feng, Hu Zhen, Rao Nan-Yan, Song Chuang-Gui, Zhang Bin, Cao Ming-Zhi, Su Feng-Xi, Wang Yong-Sheng, He Ping-Qing, Di Gen-Hong, Shen Kun-Wei, Wu Jiong, Lu Jin-Song, Luo Jian-Min, Liu Xiao-Yi, Zhou Jie, Wang Lei, Zhao Lin, Liu Yan-Bing, Yuan Wen-Tao, Yang Lin, Shen Zhen-Zhou, Huang Wei, Shao Zhi-Ming
Abstract excerpt
To have an overview of the role of BRCA1 and BRCA2 genes among Chinese high-risk breast cancer patients, we analyzed 489 such high-risk breast cancer patients from four breast disease clinical centers in China, by using PCR-DHPLC or SSCP-DNA sequencing analysis. Allelotype analysis was done at five short tandem repeat (STR) markers in or adjacent to BRCA1 on the recurrent mutation carriers. For those analyzed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
